Lifestyle
Archived — This article has been archived. The information may be outdated.
Delhi HC flags HPV vaccine rollout
Indian Express··22 Jul
Delhi High Court on July 22 termed the Centre's plan to roll out Merck's HPV vaccine Gardasil under the Universal Immunisation Programme a very serious matter. The bench heard a petition by gynecologist Dr Sujata Mittal and health entrepreneur Jitendra Chouksey flagging prior serious adverse events linked to the vaccine during an earlier rollout attempt.
Prism
What It Means For You
- Parents considering HPV vaccination for children may await clearer government safety guidance.
- The case could affect how Gardasil enters the Universal Immunisation Programme.
- Families should consult doctors while the court and ministry review prior adverse event reports.
What's Happening
- Delhi High Court called the Centre's Gardasil HPV rollout under UIP a very serious matter.
- The bench heard a petition flagging serious adverse events from an earlier rollout attempt.
- It asked Additional Solicitor General Chetan Sharma to brief health ministry officers involved.
Court Reviews HPV Rollout Safety
- An earlier 2009 trial rollout in Gujarat and Andhra Pradesh faced death reports in 2010.
- A 2013 parliamentary committee found irregularities in related clinical trials, petitioners said.
- Merck's Gardasil is being considered for inclusion in India's universal immunisation drive.
top-stories
